US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1  2  3  4    6    8  9  10  
Conjugated Drugs in Oncology Drug Pipeline Update
8/4/2016 | published by: BioSeeker Group AB
... the clinical application of ADCs is accelerating rapidly. But antibodies are not the only kind of compound one could conjugate small molecules to, nor the only class of compounds which one can yield targeted therapy ...  |  read more...
USD 6,750
Lymphoma Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... treatment strategies is based on our increasing understanding of the 288 drug targets that are included in this drug-pathway analyzing tool. No less than 267 of these have been recorded with mutations and 65 drug ...  |  read more...
USD 6,750
Colorectal Cancer Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... plethora of treatment strategies is based on our increasing understanding of the 313 drug targets that are included in this drug-pathway analyzing tool. No less than 301 of these have been recorded with mutations and ...  |  read more...
USD 6,750
Lung Cancer Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... plethora of treatment strategies is based on our increasing understanding of the 393 drug targets that are included in this drug-pathway analyzing tool. No less than 369 of these have been recorded with mutations and ...  |  read more...
USD 6,750
Prostate Cancer Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... plethora of treatment strategies is based on our increasing understanding of the 317 drug targets that are included in this drug-pathway analyzing tool. No less than 305 of these have been recorded with mutations and ...  |  read more...
USD 6,750
Hematological Cancers Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... plethora of treatment strategies is based on our increasing understanding of the 450 drug targets that are included in this drug-pathway analyzing tool. No less than 419 of these have been recorded with mutations and ...  |  read more...
USD 6,750
Renal Cancer Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... plethora of treatment strategies is based on our increasing understanding of the 223 drug targets that are included in this drug-pathway analyzing tool. No less than 215 of these have been recorded with mutations and ...  |  read more...
USD 6,750
Neuroendocrine Tumors Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... plethora of treatment strategies is based on our increasing understanding of the 114 drug targets that are included in this drug-pathway analyzing tool. No less than 106 of these have been recorded with mutations and ...  |  read more...
USD 2,250
Head and Neck Cancer Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... The rational for this plethora of treatment strategies is based on our increasing understanding of the 211 drug targets that are included in this drug-pathway analyzing tool. No less than 199 of these have been ...  |  read more...
USD 4,485
Gastrointestinal Cancer Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... plethora of treatment strategies is based on our increasing understanding of the 174 drug targets that are included in this drug-pathway analyzing tool. No less than 167 of these have been recorded with mutations and ...  |  read more...
USD 6,750
Peptides in Oncology: Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... The rational for this plethora of treatment strategies is based on our increasing understanding of the 221 drug targets that are included in this drug-pathway analyzing tool. No less than 218 of these have been ...  |  read more...
USD 6,750
The Latest Sales Figures in Oncology Drug Pipeline Update
8/4/2016 | published by: BioSeeker Group AB
... companies to progressive biotech companies. The analysis leverages the power of BioSeeker's 1stOncology intelligence which combines company disclosed product sales and detailed drug development information. The results is not only a unique insight into the ...  |  read more...
USD 4,485
Fierce 15 in Oncology Drug Pipeline Update
8/4/2016 | published by: BioSeeker Group AB
... award are aiming at breakthroughs and big things, not at being 'me-too'. This unique product, the 'Fierce 15 in Oncology Drug Pipeline Update' gathers the last six years (2010-2015) of Fierce 15 awards and identifies ...  |  read more...
USD 4,485
TCR/CAR-T Therapies in Oncology Drug Pipeline Update
8/4/2016 | published by: BioSeeker Group AB
... able to launch the first successful CAR-T therapy drug. BioSeeker’s TCR/CAR-T Therapies in Oncology Drug Pipeline Update is the most up to date and comprehensive commercial pipeline review and competitive assessment available on this hot ...  |  read more...
USD 2,985
Target Atlas in Breast Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Breast Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Prostate Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Prostate Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Colorectal Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Colorectal Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Ovarian Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Ovarian Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Liver Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Liver Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 4,485
Target Atlas in Hematological Cancers: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Hematological Cancers: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 8,850
Target Atlas in Mesothelioma: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Mesothelioma: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, integrated with drug pipeline ...  |  read more...
USD 6,750
Target Atlas in Sarcomas: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Sarcomas: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, integrated with drug pipeline ...  |  read more...
USD 6,750
Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016
6/30/2016 | published by: GlobalData
... I Hyperlipoproteinemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Familial Chylomicronemia (Type I Hyperlipoproteinemia). Report includes an overview of trial numbers and their average enrollment in top ...  |  read more...
USD 2,500
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016
6/30/2016 | published by: GlobalData
... II Hyperlipoproteinemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Familial Hypercholesterolemia (Type II Hyperlipoproteinemia). Report includes an overview of trial numbers and their average enrollment in top ...  |  read more...
USD 2,500
Hyperbilirubinemia Global Clinical Trials Review, H1, 2016
6/30/2016 | published by: GlobalData
... to the clinical trials on Hyperbilirubinemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ...  |  read more...
USD 2,500
1  2  3  4    6    8  9  10